Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
Add more filters










Publication year range
1.
Ann Oncol ; 27(5): 862-7, 2016 05.
Article in English | MEDLINE | ID: mdl-26823523

ABSTRACT

BACKGROUND: The aim of this pilot study was to assess whether both ubiquitous and heterogeneous somatic mutations could be detected in cell-free DNA (cfDNA) from patients with early-stage non-small-cell lung cancer (NSCLC). PATIENTS AND METHODS: Three stage I and one stage II primary NSCLC tumors were subjected to multiregion whole-exome sequencing (WES) and validated with AmpliSeq. A subset of ubiquitous and heterogeneous single-nucleotide variants (SNVs) were chosen. Multiplexed PCR using custom-designed primers, coupled with next-generation sequencing (mPCR-NGS), was used to detect these SNVs in both tumor DNA and cfDNA isolated from plasma obtained before surgical resection of the tumors. The limit of detection for each assay was determined using cfDNA from 48 presumed-normal healthy volunteers. RESULTS: Tumor DNA and plasma-derived cfDNA was successfully amplified and sequenced for 37/50 (74%) SNVs using the mPCR-NGS method. Twenty-five (68%) were ubiquitous and 12 (32%) were heterogeneous SNVs. Variant detection by mPCR-NGS and WES-AmpliSeq in tumor tissue was well correlated (R(2) = 0.8722, P < 0.0001). Sixteen (43%) out of 37 SNVs were detected in cfDNA. Twelve of these were ubiquitous SNVs with a variant allele frequency (VAF) range of 0.15-23.25%, and four of these were heterogeneous SNVs with a VAF range of 0.28-1.71%. There was a statistically significant linear relationship between the VAFs for tumor and cfDNA (R(2) = 0.5144; P = 0.0018). For all four patients, at least two variants were detected in plasma. The estimated number of copies of variant DNA present in each sample ranged from 5 to 524. The average number of variant copies required for detection (VCRD) was 3.16 (range: 0.2-7.6 copies). CONCLUSIONS: The mPCR-NGS method revealed intratumor heterogeneity in early-stage NSCLC tumors, and was able to detect both ubiquitous and heterogeneous SNVs in cfDNA. Further validation of mPCR-NGS in cfDNA is required to define its potential use in clinical practice.


Subject(s)
Carcinoma, Non-Small-Cell Lung/genetics , Cell-Free Nucleic Acids/genetics , DNA, Neoplasm/genetics , Exome Sequencing , Aged , Carcinoma, Non-Small-Cell Lung/blood , Carcinoma, Non-Small-Cell Lung/pathology , Cell-Free Nucleic Acids/blood , DNA, Neoplasm/blood , Female , Genetic Heterogeneity , Humans , Male , Middle Aged , Mutation , Neoplasm Staging , Polymorphism, Single Nucleotide/genetics
3.
Aliment Pharmacol Ther ; 28(2): 256-65, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18462266

ABSTRACT

BACKGROUND: The pharmacokinetics of polyethylene glycol 3350 (PEG-3350) have not been fully described because of lack of a sufficiently sensitive analytical method. AIM: To describe the pharmacokinetics of PEG-3350 in humans. METHODS: A highly sensitive, high performance liquid chromatography with mass spectrometry (HPLC/MS/MS) method was developed for PEG-3350 in urine, plasma and faeces with quantification limits of 30 ng/mL, 100 ng/mL and 500 microg/g respectively. Noncompartmental pharmacokinetics methods were used and the effects of gender, age, renal status and dosing frequency were examined after the oral administration of 17 g to healthy volunteers. RESULTS: Peak PEG-3350 plasma concentrations occurred at 2-4 h and declined to nonquantifiable levels usually within 18 h after single and multiple doses, with a half-life of about 4-6 h. Steady state was reached within 5 days of dosing. Mean urinary excretion of the administered dose ranged from 0.19% to 0.25%. Age, gender or mild kidney impairment did not alter the pharmacokinetics of PEG-3350. Mean faecal excretion of the administered dose was 93% in young subjects. CONCLUSIONS: For the first time, a highly sensitive assay allowed comprehensive pharmacokinetics studies of PEG-3350 in humans. These studies confirmed that orally administered PEG-3350 is minimally absorbed, rapidly excreted and primarily eliminated via faeces.


Subject(s)
Chromatography, High Pressure Liquid/methods , Mass Spectrometry/methods , Polyethylene Glycols/pharmacokinetics , Adult , Age Factors , Aged , Female , Humans , Male , Middle Aged , Polyethylene Glycols/administration & dosage , Sex Factors
4.
Nat Cell Biol ; 3(3): 235-44, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11231572

ABSTRACT

Factors that are involved in actin polymerization, such as the Arp2/3 complex, have been found to be packaged into discrete, motile, actin-rich foci. Here we investigate the mechanism of actin-patch motility in S. pombe using a fusion of green fluorescent protein (GFP) to a coronin homologue, Crn1p. Actin patches are associated with cables and move with rates of 0.32 microm s(-1) primarily in an undirected manner at cell tips and also in a directed manner along actin cables, often away from cell tips. Patches move more slowly or stop when actin polymerization is attenuated by Latrunculin A or in arp3 and cdc3 (profilin) mutants. In a cdc8 (tropomyosin) mutant, actin cables are absent, and patches move with similar speed but in a non-directed manner. Patches are sites of Arp3-dependent F-actin polymerization in vitro. Rapid F-actin turnover rates in vivo indicate that patches and cables are maintained continuously by actin polymerization. Our studies give rise to a model in which actin patches are centres for actin polymerization that drive their own movement on actin cables using Arp2/3-based actin polymerization.


Subject(s)
Actins/metabolism , Contractile Proteins , Cytoskeletal Proteins , Cytoskeleton/metabolism , Schizosaccharomyces pombe Proteins , Schizosaccharomyces/physiology , Actin-Related Protein 2 , Actin-Related Protein 3 , Bridged Bicyclo Compounds, Heterocyclic/pharmacology , Cell Cycle Proteins/genetics , Cell Cycle Proteins/metabolism , Fluorescent Dyes/metabolism , Genes, Reporter , Green Fluorescent Proteins , Kinetics , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Microfilament Proteins/genetics , Microfilament Proteins/metabolism , Microscopy, Confocal , Microscopy, Video , Polymers/metabolism , Profilins , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Schizosaccharomyces/genetics , Temperature , Thiazoles/pharmacology , Thiazolidines , Time Factors , Tropomyosin/metabolism
6.
J Histochem Cytochem ; 47(12): 1644B-1644, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10567454
7.
Science ; 286(5442): 1172-4, 1999 Nov 05.
Article in English | MEDLINE | ID: mdl-10550057

ABSTRACT

Focal adhesions (FAs) are clustered integrins and associated proteins that mediate cell adhesion and signaling. A green fluorescent protein-beta1 integrin chimera was used to label FAs in living cells. In stationary cells, FAs were highly motile, moving linearly for several plaque lengths toward the cell center. FA motility was independent of cell density and resulted from contraction of associated actin fibers. In migrating cells, FAs were stationary and only moved in the tail. FA motility in stationary cells suggests that cell movement may be regulated by a clutch-like mechanism by which the affinity of integrins to substrate may be altered in response to migratory cues.


Subject(s)
Cell Adhesion , Cell Movement , Fibroblasts/cytology , Integrin beta1/metabolism , 3T3 Cells , Actins/physiology , Animals , Cell Count , Cell Line , Fibroblasts/metabolism , Fluorescence , Green Fluorescent Proteins , Luminescent Proteins , Mice , Microscopy, Interference , Rats , Recombinant Fusion Proteins/metabolism
9.
J Urol ; 162(3 Pt 1): 726-30; discussion 730-1, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10458353

ABSTRACT

PURPOSE: We compare the systemic effects, local tolerance and effectiveness of topical gel formulations on the penis containing alprostadil (prostaglandin E1) plus 5% SEPA versus SEPA alone (placebo) in men with erectile dysfunction. MATERIALS AND METHODS: Erectile response, skin discomfort and erythema were measured in 48 men with erectile dysfunction secondary to vascular, neurogenic, psychogenic or mixed etiologies in this single-blind, placebo controlled trial. RESULTS: Application of prostaglandin E1 gel correlated positively with erectile response as 67 to 75% of patients had an erection compared to 17% of controls (p<0.001). Blood pressure and heart rate varied minimally. No serious adverse effects were observed in the 48 patients, although the majority had skin discomfort. CONCLUSIONS: Topical prostaglandin E1 gel applied to the penis appears to be safe, and facilitates audiovisual and tactile stimulation resulting in an erection when given in a clinic setting. Consequences to the female partner remain unknown.


Subject(s)
Alprostadil/therapeutic use , Erectile Dysfunction/drug therapy , Vasodilator Agents/therapeutic use , Adjuvants, Pharmaceutic/administration & dosage , Administration, Topical , Dioxolanes/administration & dosage , Drug Combinations , Drug Eruptions/epidemiology , Drug Eruptions/etiology , Erectile Dysfunction/etiology , Gels , Humans , Male , Penile Erection , Single-Blind Method
10.
Mol Biol Cell ; 10(4): 935-45, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10198048

ABSTRACT

We have developed a new approach to detect mechanical forces exerted by locomoting fibroblasts on the substrate. Cells were cultured on elastic, collagen-coated polyacrylamide sheets embedded with 0. 2-micrometer fluorescent beads. Forces exerted by the cell cause deformation of the substrate and displacement of the beads. By recording the position of beads during cell locomotion and after cell removal, we discovered that most forces were radially distributed, switching direction in the anterior region. Deformations near the leading edge were strong, transient, and variable in magnitude, consistent with active local contractions, whereas those in the posterior region were weaker, more stable, and more uniform, consistent with passive resistance. Treatment of cells with cytochalasin D or myosin II inhibitors caused relaxation of the forces, suggesting that they are generated primarily via actin-myosin II interactions; treatment with nocodazole caused no immediate effect on forces. Immunofluorescence indicated that the frontal region of strong deformation contained many vinculin plaques but no apparent concentration of actin or myosin II filaments. Strong mechanical forces in the anterior region, generated by locally activated myosin II and transmitted through vinculin-rich structures, likely play a major role in cell locomotion and in mechanical signaling with the surrounding environment.


Subject(s)
Cell Movement/physiology , Cytoskeleton/physiology , 3T3 Cells , Acrylic Resins , Actins/metabolism , Animals , Cell Movement/drug effects , Cell Size , Collagen , Cytochalasin D/pharmacology , Elasticity , Fluorescent Dyes , Mice , Myosins/antagonists & inhibitors , Myosins/metabolism , Nocodazole/pharmacology , Stress, Mechanical , Time Factors , Vinculin/analysis
14.
Proc Natl Acad Sci U S A ; 94(25): 13661-5, 1997 Dec 09.
Article in English | MEDLINE | ID: mdl-9391082

ABSTRACT

Responses of cells to mechanical properties of the adhesion substrate were examined by culturing normal rat kidney epithelial and 3T3 fibroblastic cells on a collagen-coated polyacrylamide substrate that allows the flexibility to be varied while maintaining a constant chemical environment. Compared with cells on rigid substrates, those on flexible substrates showed reduced spreading and increased rates of motility or lamellipodial activity. Microinjection of fluorescent vinculin indicated that focal adhesions on flexible substrates were irregularly shaped and highly dynamic whereas those on firm substrates had a normal morphology and were much more stable. Cells on flexible substrates also contained a reduced amount of phosphotyrosine at adhesion sites. Treatment of these cells with phenylarsine oxide, a tyrosine phosphatase inhibitor, induced the formation of normal, stable focal adhesions similar to those on firm substrates. Conversely, treatment of cells on firm substrates with myosin inhibitors 2,3-butanedione monoxime or KT5926 caused the reduction of both vinculin and phosphotyrosine at adhesion sites. These results demonstrate the ability of cells to survey the mechanical properties of their surrounding environment and suggest the possible involvement of both protein tyrosine phosphorylation and myosin-generated cortical forces in this process. Such response to physical parameters likely represents an important mechanism of cellular interaction with the surrounding environment within a complex organism.


Subject(s)
Cell Adhesion/physiology , Cell Movement/physiology , 3T3 Cells , Acrylic Resins , Animals , Arsenicals/pharmacology , Biomechanical Phenomena , Cell Adhesion/drug effects , Cell Line , Collagen , Enzyme Inhibitors/pharmacology , Extracellular Matrix/metabolism , Mice , Myosins/antagonists & inhibitors , Myosins/physiology , Phosphotyrosine/metabolism , Protein Tyrosine Phosphatases/antagonists & inhibitors , Rats , Surface Properties , Vinculin/metabolism
15.
J Cell Sci ; 109 ( Pt 5): 981-9, 1996 May.
Article in English | MEDLINE | ID: mdl-8743945

ABSTRACT

Although non-muscle tropomyosins (TM) have been implicated in various cellular functions, such as stabilization of actin filaments and possibly regulation of organelle transport, their physiological role is still poorly understood. We have probed the role of a high molecular mass isoform of human fibroblast TM, hTM3, in regulating organelle transport by microinjecting an excess amount of bacterially-expressed protein into normal rat kidney (NRK) epithelial cells. The microinjection induced the dramatic retrograde translocation of organelles into the perinuclear area. Microinjection of hTM5, a low molecular mass isoform had no effect on organelle distribution. Fluorescent staining indicated that hTM3 injection stimulated the retrograde movement of both mitochondria and lysosomes. Moreover, both myosin I and cytoplasmic dynein were found to redistribute with the translocated organelles to the perinuclear area, indicating that these organelles were able to move along both microtubules and actin filaments. The involvement of microtubules was further suggested by the partial inhibition of hTM3-induced organelle movement by the microtubule-depolymerizing drug nocodazole. Our results, along with previous genetic and antibody microinjection studies, suggest that hTM3 may be involved in the regulation of organelle transport.


Subject(s)
Organelles/physiology , Tropomyosin/physiology , Actins/ultrastructure , Animals , Biological Transport/physiology , Cell Line , Humans , Microinjections , Molecular Weight , Rats , Tropomyosin/chemistry
18.
Alcohol Clin Exp Res ; 4(3): 282-7, 1980 Jul.
Article in English | MEDLINE | ID: mdl-6994921

ABSTRACT

Prolonged ethanol consumption produces neuropathology and neurologic symptoms in humans and experimental animals. As a means of understanding the central nervous system (CNS) consequences of ethanol abuse, we sought whether cholinergic neurochemical functions were altered by long-term ethanol consumption by rats. Eighteen weeks of ethanol consumption in a liquid diet reduced rat striatal and mammillary body choline acetylase (ChAT) by 53% and 58%, respectively. In these same regions, the density of muscarinic cholinergic receptors was elevated 117% and 12%. No such alterations were observed in cortex or in hippocampus. No alterations followed short-term ethanol consumption (2 wk), but they persisted after ethanol withdrawal (4 wk). After 13 mo of ethanol consumption, the number of neuroleptic binding sites in striatum was diminished by 29%. These results demonstrate a persistent, possibly permanent, alteration in brain cholinergic function as a consequence of long-term ethanol ingestion. Since brain acetylcholine is involved in numerous neurologic functions, including memory processes, these findings may be relevant to the lasting memory disorder and other permanent effects associated with chronic alcoholism.


Subject(s)
Alcoholism/metabolism , Brain/metabolism , Parasympathetic Nervous System/metabolism , Animals , Choline O-Acetyltransferase/metabolism , Diet , Ethanol/blood , Haloperidol/metabolism , Humans , Kinetics , Male , Quinuclidinyl Benzilate/metabolism , Rats , Synapses/drug effects
19.
Neurobiol Aging ; 1(1): 13-9, 1980.
Article in English | MEDLINE | ID: mdl-7266730

ABSTRACT

Age related alterations in mnemonic ability and in the functional status of muscarinic receptors were evaluated and compared to biochemical measures of pre and post-synaptic cholinergic functioning. Retention of a single trial passive avoidance task was considerably disturbed as a function of aging. The functional status of muscarinic receptors, as measured by the ability of microiontophoretically applied acetylcholine to stimulate the firing of hippocampal pyramidal cells, was similarly disturbed in aged rats. A small, but significant decrease in muscarinic receptors was detected in the dorsal hippocampi of these same aged rats, while choline acetyltransferase activity did not change. When considered with prior psychopharmacological studies, these data suggest that specific muscarinic receptor impairments may play a critical role in the memory disturbances associated with old age.


Subject(s)
Acetylcholine/physiology , Aging , Cholinergic Fibers/physiology , Hippocampus/physiology , Memory/physiology , Mental Recall/physiology , Receptors, Cholinergic/physiology , Receptors, Muscarinic/physiology , Animals , Avoidance Learning/physiology , Glutamates/physiology , Rats , Rats, Inbred F344 , Retention, Psychology/physiology
20.
Brain Res ; 171(3): 473-80, 1979 Aug 10.
Article in English | MEDLINE | ID: mdl-476482

ABSTRACT

[3H]Quinuclidinyl benzilate (QNB) binds to specific muscarinic receptors of rat striatum, in vivo. The binding is saturable and displaceable by muscarinic drugs. Clozapine and thioridazine are unique antipsychotic agents with low liability for extrapyramidal side-effects, and both displaced ONB, while several other neuroleptics did not. In addition to this apparent direct competition for cholinergic receptors, morphine and amphetamine increased ONB binding by indirect influences on muscarinic receptors. In vivo QNB binding not only confirms in vitro findings, but it also detects indirect, probably transsynaptic, alterations of muscarinic cholinergic receptor dynamics.


Subject(s)
Corpus Striatum/metabolism , Quinuclidines/metabolism , Quinuclidinyl Benzilate/metabolism , Receptors, Cholinergic/metabolism , Receptors, Muscarinic/metabolism , Animals , Binding, Competitive/drug effects , Cerebellum/metabolism , Corpus Striatum/drug effects , Dose-Response Relationship, Drug , Male , Psychotropic Drugs/pharmacology , Quinuclidinyl Benzilate/administration & dosage , Rats , Receptors, Muscarinic/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...